(Q40795774)

23 September 2017

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma (English)

1 reference

23 September 2017

1 reference

11

Jaffe ES

1 reference

23 September 2017

13

Longo DL

1 reference

23 September 2017

Bendandi M

1

1 reference

23 September 2017

Gocke CD

2

1 reference

23 September 2017

Kobrin CB

3

1 reference

23 September 2017

Benko FA

4

1 reference

23 September 2017

Sternas LA

5

1 reference

23 September 2017

Pennington R

6

1 reference

23 September 2017

Watson TM

7

1 reference

23 September 2017

Reynolds CW

8

1 reference

23 September 2017

Gause BL

9

1 reference

23 September 2017

Duffey PL

10

1 reference

23 September 2017

Creekmore SP

12

1 reference

23 September 2017

Kwak LW

14

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

23 September 2017

1 reference

23 September 2017

5

1 reference

23 September 2017

1171-1177

1 reference

23 September 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/13928

23 September 2017

0 references

cites work

Antibody to a molecularly-defined antigen confined to a tumour cell surface

1 reference

Myeloma proteins as tumor-specific transplantation antigens

21 January 2018

1 reference

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

21 January 2018

1 reference

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response

21 January 2018

1 reference

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

Using the polymerase chain reaction to estimate mutation frequencies and rates in human cells

21 January 2018

1 reference

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

21 January 2018

1 reference

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

21 January 2018

1 reference

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

21 January 2018

1 reference

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

21 January 2018

1 reference

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

21 January 2018

1 reference

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

21 January 2018

1 reference

Development of vaccine strategies for the treatment of B-cell malignancies

21 January 2018

1 reference

Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity

21 January 2018

1 reference

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

21 January 2018

1 reference

7 January 2021

Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification

1 reference

7 January 2021

Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype

1 reference

7 January 2021

Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies

1 reference

7 January 2021

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy

1 reference

7 January 2021

Measurement of macrophage-mediated cytotoxicity against adherent and non-adherent target cells by release of 111indium-oxine

1 reference

7 January 2021

Identifiers

DOI

10.1038/13928

1 reference

23 September 2017

1 reference